Skip to main content
. 2018 Nov 3;13:213. doi: 10.1186/s13014-018-1156-1

Table 3.

Descriptive outcome analysis

Status n %
Alive 131 66.8
Deceased 62 31.6
Unknown 3 1.6
Death from lung cancer 34 17.3
 Locoregional failure 12 6.2
 Distant progression 22 11.2
Death from comorbidities 28 14.3
 cardiovascular 8 4.1
 lung 6 3.1
 infection 4 2.0
 stroke 3 1.5
 other 7 3.6